Anti-parasitic Applications of Nanoparticles
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 1995
Special Issue Editors
Interests: nanomaterials; biotechnology
Special Issue Information
Dear Colleagues,
Parasitic infections pose a significant public health concern, characterized by elevated morbidity and mortality rates and affecting millions of individuals across the globe. Addressing parasitic diseases proves to be an arduous task, as evidenced by the ongoing transmission and the substantial mortality rates associated with these conditions. Current therapeutic protocols predominantly rely on the application of conventional chemical agents or natural compounds, most of which have become outdated. There is a pressing need for enhancements to overcome various challenges, including low drug bioavailability, inadequate drug accumulation in microbial sanctuaries and reservoirs, rising drug resistance, and diminished patient adherence due to drug-induced toxicities and protracted treatment regimens. Notably, several types of nanoparticles have shown promise as therapeutic and adjunctive interventions for parasitic diseases. The primary objective of this Special Issue is to disseminate research articles that showcase advancements in anti-parasitic applications of nanoparticles, with a specific focus on:
- Nano-based therapies for parasitic diseases;
- Nanotechnologies used for drug development;
- Nanoparticle–parasite interactions;
- Nanoparticle applications to reduce drug-resistance.
In this Special Issue, original research articles and reviews are welcome.
Prof. Dr. Anielle Christine Almeida Silva
Prof. Dr. Marcos Vinícius Da Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- parasitic diseases
- drug resistance
- nanodelivery systems
- nanoemulsion
